Katalin Karikó, author portrait
© Matthew Hamilton/Vilcek Foundation

Katalin Karikó

Katalin Karikó, PhD, is a Hungarian American biochemist who specializes in RNA-mediated mechanisms. She is an adjunct professor of neurosurgery at the University of Pennsylvania, and her research was foundational in the development of the Pfizer-BioNTech and Moderna mRNA vaccines.
Breaking Through

Books

Breaking Through

Register for the 2026 Penguin Random House First-Year Experience® Conference Author Events!

Penguin Random House Author Events at the 45th Annual First-Year Experience® Conference February 15-18, 2026 Seattle, Washington Hyatt Regency Seattle Click Here to RSVP A complimentary meal and a limited number of books will be available to attendees. Each event will also be followed by an author signing. Interested in hosting one of these authors at

Read more

What Students Will Be Reading: Campus Common Reading Roundup, 2025-26

With the fall semester in full swing, colleges and universities around the country have announced their Common Reading books for the upcoming 2025-26 academic year. We’ve compiled a list of over 284 programs and their title selections from publicly available sources, which you can download here: First-Year Reading 2025-26. We will continue to update this

Read more

2026 Catalog for First-Year & Common Reading

We are delighted to present our new First-Year & Common Reading Catalog for 2026! From award-winning fiction, poetry, memoir, and biography to new books about the environment, current events, history, public health, science, social justice, student success, and technology, the titles presented in our common reading catalog will have students not only eagerly flipping through

Read more

Breaking Through Author Katalin Karikó Awarded the 2023 Nobel Prize in Physiology or Medicine

Long before the search for a COVID-19 vaccine, the visionary, Hungarian-born biochemist Katalin Karikó knew that an ephemeral and underappreciated molecule called messenger RNA could change the world. Karikó worked for more than three decades at her lab bench, in the single-minded pursuit of a breakthrough that would confirm her hunch: that mRNA could transform ordinary cells into tiny factories

Read more